Navigation Links
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
Date:5/14/2012

28,22972,342Interest expense(1,830)(1,974)(6,650)(5,607)Increase in fair value of warrants-(1,257,691)-(1,257,691)Gain on sale of securities-58,956-119,346Gain (loss) on sale of supplies and equipment1,700(7,466)4,700(5,666)Total other income (expense)5,825(1,189,193)26,279(1,077,276)Loss before income taxes(6,020,702)(3,805,878)(13,068,118)(10,144,091)Income tax benefit--1,068,233637,391NET LOSS$   (6,020,702)$  (3,805,878)$  (11,999,885)$  (9,506,700)Basic and diluted net loss per common share$
(0.17)$
(0.17)$
(0.34)$
(0.65)Weighted average number of common sharesoutstanding used in computing basic and

diluted net loss per common share34,900,59122,832,10934,900,59114,669,131 

 PALATIN TECHNOLOGIES, INC.and Subsidiary

 Consolidated Balance Sheets

(unaudited)March 31,
2012June 30,
2011ASSETSCurrent assets:Cash and cash equivalents$
8,770,249$
8,869,639Accounts receivable16,600131,149Prepaid expenses and other current assets673,393261,947Total current assets9,460,24219,262,735Property and equipment, net583,2111,305,331Restricted cash350,000350,000Other assets59,233254,787Total assets$
,452,686$
21,172,853LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Capital lease obligations$
21,856$
34,923Accounts payable557,902496,908Accrued compensation80,728374,094Unearned revenue-46,105Accrued expenses2,776,3911,854,007Total current liabilities3,436,8772,806,037Capital lease obligations25,63842,186Deferred rent81,981132,855Total liabilities3,544,4962,981,078Stockholders' equity:Preferred stock of $.01 par value – authorized 10,000,000 shares;Series A Convertible; issued and outstanding 4,997 shares as of March 31, 2012 and June 30, 2011, respectively5050Common stock of $.01 par value – authorized 100,000,000 sharesissued and outstanding 34,900,591 shares as of March 31, 2012and June 30, 2011, respectively349,006349,006Additional paid-in capital2
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
2. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
3. Palatin Technologies to Report Fiscal Year 2009 First Quarter Results; Conference Call and Webcast on November 17, 2008
4. Palatin Technologies Receives Notification Letter from NYSE Alternext US
5. Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009
6. Palatin Technologies Listing Compliance Plan Accepted by NYSE Alternext US
7. Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
8. Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration
9. Palatin Technologies, Inc. to Raise $3.1 Million in Registered Direct Offering
10. Palatin Technologies to Present at the Rodman & Renshaw 11th Annual Global Investment Conference
11. Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year 2009 Results; Teleconference and Webcast to be held on September 8, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy & ... it has signed a letter of intent to ... developed and patented a nanotechnology-based development platform used ... that enable rapid on-site collection and testing to ... health issues in an immediate, non-invasive and cost-effective ...
(Date:12/22/2014)... 22, 2014 ITRA Global, one of ... of commercial real estate, has further expanded its global ... Perth and Brisbane, Western Australia, reports Mylinda Vick, CCIM, ... ITRA Global / ACORPP (Australian Corporate Property and ... company providing property services to a wide range of ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the ... Maroulis, Pharm.D. to the newly created position of Vice ... position, Dr. Maroulis will continue to manage the entire ... multi-site pharmacies as the company expands. Dr. Maroulis has ... he has served in many different capacities in the ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 19, 2014 ... biomaterial market will grow at a 12 percent compound ... a result of the aging population and the increasing ... Latin America will also spur demand ... results of dental implant and periodontal treatments. ...
Breaking Biology Technology:ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3
... now lost as heat during the production of ... silicon nanowires synthesized via a technique developed by ... Lawrence Berkeley National Laboratory (Berkeley Lab) and the ... potential applications of this technology include DOEs hydrogen ...
... NEW YORK, January 10 HealthCare Technologies,Ltd., (the ... dated,January 7, 2008 from the Staff of the ... Stock Market LLC, which indicated,that because the Staff ... Biofuels, Inc., which closed on December 31, 2007, ...
... Seven Summits Research issues,PriceWatch Alerts for key stocks., ... at, http://www.iotogo.com/s/011008B (Note: You may have ... [ENTER] key.), Today,s PriceWatch Alerts cover the following ... & Co., Inc. (NYSE: MER ), DryShips, Inc. ...
Cached Biology Technology:Feeling the heat 2Feeling the heat 3Feeling the heat 4HealthCare Technologies Ltd. (NASDAQ: HCTL) Announces Receipt of NASDAQ Delisting Notice 2Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI 2Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI 3
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... Ireland, the number of people surviving the disease in the ... year there are between 50-60 men and women who survive ... The survival rates in Northern Ireland for cancers including ... and its patients are benefiting from improved treatment outcomes by ...
... This release is available in German . According ... the Lily of the Valley scent known as Bourgeonal alters the calcium ... Valley phenomenon" also the title of a book about smelling ... swimming olfactory cells which follow a "scent trail" laid by the egg. ...
... the aid of light: this is made possible ... of neurobiological processes with unprecedented spatial and temporal ... light-activated protein channelrhodopsin. Biophysicists from Bochum and Berlin ... through an interdisciplinary approach. The researchers report on ...
Cached Biology News:More people surviving cancer in Northern Ireland 2The end of the 'Lily of the Valley phenomenon' in sperm research? 2The end of the 'Lily of the Valley phenomenon' in sperm research? 3Optogenetic tool elucidated 2
... Imaging Systems group announces the availability ... Imaging Systems, featuring high resolution cooled ... luminescence, radiographic and chromogenic imaging capability. ... and 10x optical zoom lens provides ...
... that oxidative stress is involved in atherosclerosis, ... is the condition in which an imbalance ... leading to the damage of a cell. ... is through several antioxidant systems4 that include ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential Neurological liabilities of compound...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
Biology Products: